Viewing Study NCT06210334


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-27 @ 11:03 PM
Study NCT ID: NCT06210334
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-20
First Post: 2024-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)
Sponsor: Li Xiao Wei
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module